| 【Company Research】China Tower (788 HK) - 1H26 results: D&A roll-off drove earnings amid revenue decline; Maintain HOLD |
| 【Company Research】Tencent (700 HK) - Solid 2Q26 results; gradually capturing AI benefits in the long run |
| 【Company Research】Kingdee (268 HK) - AI-native revenue ramping up |
| 【Company Research】Lumentum (LITE US) - Q4 earnings beat; optical momentum continues across multiple architectures |
| 【Company Initiation】Laifual Drive (3952 HK) - A cost-driven disruptor in harmonic reducer market to ride humanoid robotics wave |
| 【Company Research】TME (TME US) - 2Q26 results: Navigating competition headwinds |
| 【Sector Research】Internet - Implications from earnings beats by North American cloud majors |
| 【Sector Research】Asia Insurance - Offshore insurance tax sell-off likely overdone |
| 【Company Research】Datadog (DDOG US) - Results beat; still a key beneficiary in AI era |
| 【Company Research】BeOne Medicines (ONC US) - Hematology dominance meets solid tumor inflection |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
